Skip Navigation
Bookmark and Share
.
Clinical Decision Making
Clinical Decision Making
Prescription drugs are prescribed during clinical encounters. Thorough and effective patient-provider communication about the benefits, risks, costs and alternatives to prescription medicines is a vital part of clinical care. The Center supports research and advocacy to identify and overcome barriers to patient-provider communication to improve safe medication use and to maximize adherence.
Comparative Effectiveness
Comparative Effectiveness
For stakeholders to make informed decisions about prescription drug use, they need timely evidence about the comparative effectiveness of therapies and their alternatives, including their risks and benefits. Incomplete evidence contributes to overuse of some therapies, underuse of others and risky prescribing. The Center supports innovative research into these topics.
Global Medicines
Global Medicines
Ensuring adequate access and affordability of prescription medicines poses major and unique challenges for countries around the world. These challenges are particularly salient in emerging economies that account for an increasing proportion of the world's population and pharmaceutical expenditures. Center investigators focus on how public policy can be optimized to maximize global drug availability and access.
Medication Safety
Medication Safety
Some adverse effects of medicines only come to light after medications have been on the market and widely used. Center investigators are working to develop new methods for identifying risk, to predict the likelihood of high-risk medicines or drug combinations and to protect the public from excessive exposure to these products.
Policy Analyses
Policy Analyses
Complex and dynamic policies govern prescription drug regulation. Policymakers face the challenge of maximizing innovation while protecting public health, and developing payment policies that promote evidence-based usage. Center investigators evaluate regulatory policies to provide policymakers with information to continually optimize pharmaceutical regulation.
Prescription Abuse
Prescription Abuse
Prescription drugs provide therapeutic value to millions of Americans. At the same time, rates of prescription drug abuse and overdose deaths are skyrocketing. The annual number of fatal drug overdoses in the United States now surpasses those of motor vehicle deaths. The Center supports innovative research and public advocacy to help stem this epidemic.

Welcome

Prescription drugs help millions of people in the United States and around the world. However, they are not without risk. The Center for Drug Safety and Effectiveness seeks to improve the safe and effective use of medications by bringing together researchers at Johns Hopkins to accomplish a fourfold mission – training, research, patient care and public service – towards best medication practices.

Commissioner's Lecture

hamburg

In October 2013, we celebrated our first year with a visit from the FDA Commissioner, Dr. Margaret Hamburg.  In addition to delivering an inspiring lecture about the important role that academic institutions can play in promoting the safe and effective use of prescription drugs, Dr. Hamburg also joined Dr. Tom Burke for a Public Health on the Inside podcast and met with faculty and students. 


Click here for our Center At A Glance

Featured Event

rxtownhall2015

Given the morbidity and mortality associated with prescription drug abuse, as well as the central role that pharmacoepidemiology plays in understanding this epidemic and evaluating interventions to address it, the Center for Drug Safety and Effectiveness was delighted to host the Town Hall held November 17, 2015. View the event page and official report here

Featured Faculty

Ariel Green, MD, MPH

agreenThe Center for Drug Safety and Effectiveness is delighted to have Ariel Green as one of its newest core faculty. Dr. Green is an Assistant Professor of Medicine and practices in the field of geriatric medicine. Her research focuses on improving the care of older adults with disabling combinations of conditions and decision-making surrounding the use of potentially inappropriate medications and invasive medical technologies in vulnerable older adults. 

Upcoming

'Safety, Value and Innovation' Seminar Series
Kenneth Park, MD
Vice President
Real-World Evidence Solutions
IMS Health
 
Monday, May 9, 2016
E9519, Wolfe Street Building
Click here for more information and upcoming seminars

Newsworthy

.
Subscribe:
  • Receive our Johns Hopkins
    Public Health Magazine,
    Public Health News
.